NK DLI after HLA-Haploidentical HSCT
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for NK DLI after HLA-Haploidentical HSCT, covering 2024-03-19 to 2024-03-19. Get the full timeline:
Most recent: Clinical Trial Update: NK DLI in Patients After Human Leukocyte Antigen (HLA)-Haploidentical Hematopoietic Stem Cell Transplantation (HSCT) [Phase 1, Phase 2]